Cardiovascular Therapeutics
Journal metrics
Annual Clarivate and SCImago indicators.
| Year | JCR | SJR | ||||
|---|---|---|---|---|---|---|
| IF | IF quartile | Rank (percentile) | SJR | SJR quartile | Rank (percentile) | |
| 2025 | 2.8 | Q2 | 57.8% | 0.857 | Q2 | 79.5% |
| 2024 | 3.4 | Q2 | 73.5% | 0.831 | Q2 | 79.0% |
| 2023 | 3.4 | Q2 | 71.3% | 0.769 | Q2 | 78.5% |
| 2022 | 3.1 | Q2 | 55.0% | 0.790 | Q2 | 80.2% |
| 2021 | 3.4 | Q3 | 57.5% | 0.725 | Q2 | 78.4% |
| 2020 | — | — | 0.818 | Q2 | 80.4% | |
| 2019 | — | — | 0.839 | Q2 | 81.5% | |
| 2018 | — | — | 0.780 | Q2 | 77.9% | |
Impact history
Annual SJR and Impact Factor trend.
SJRIF
Journal record
eISSN
1755-5922
ISSN
1755-5914
country
CNcoverage
2008-2026